Diebold Nixdorf (DBD) Tops Q1 EPS by 5c; offers guidance
Get Alerts DBD Hot Sheet
Price: $62.72 +0.40%
Financial Fact:
Income from continuing operations: -20.8M
Today's EPS Names:
OCCI, IPX, ALZN, More
Financial Fact:
Income from continuing operations: -20.8M
Today's EPS Names:
OCCI, IPX, ALZN, More
Join SI Premium – FREE
Diebold Nixdorf (NYSE: DBD) reported Q1 EPS of $0.67, $0.05 better than the analyst estimate of $0.62. Revenue for the quarter came in at $891.8 million, versus $0 reported last year.
GUIDANCE:
Diebold Nixdorf sees FY2026 EPS of $5.25-$5.75, versus the consensus of $5.49. Diebold Nixdorf sees FY2026 revenue of $3.86-3.94 billion, versus the consensus of $3.902 billion.
For earnings history and earnings-related data on Diebold Nixdorf (DBD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- OpenAI: after the Hugging Face incident, we committed to conducting a much broader review of actions taken by our models
- Krait Critical Minerals closes $1.22M first tranche of placement
- Boeing and Bell Boeing receive defense contracts totaling $56.4M
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share